Panorama

Health of King Harald V of Norway worsens

The 89-year-old Norwegian monarch is being treated for health issues following a recent deterioration in his condition, raising concerns.

23 August 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Health of King Harald V of Norway worsens — Archive photoPhoto: Jungpionier · Wikimedia Commons · CC BY-SA 3.0

The health condition of King Harald V of Norway deteriorated over the weekend. The 89-year-old monarch has been hospitalized since Monday, where he is being treated with antibiotics for a bacterial infection of the bloodstream.

According to a statement from the Norwegian Royal House, the king's health is assessed as 'stable'; however, the deterioration of his condition is significant. The king has faced several health issues in recent years but has not considered retirement.

In recent days, several members of the royal family have gathered at his hospital bedside, underscoring the concerns about his health. Since his ascension in 1991, the monarch has frequently battled health challenges.

King Harald suffers from hemolytic anemia, a condition that leads to the faster destruction of red blood cells, complicating his current situation. This information has been confirmed by both la Libre Belgique and Clarín.

Reports indicate that the king has been responding well to treatment during his hospital stay. The Royal House has announced that he will continue to receive care while his family looks after him. Meanwhile, the situation remains closely monitored among relatives.

Public interest in the king's health is high, especially given his long reign as monarch. The coming days will be crucial for the development of his condition, and reporting on his health status is expected to continue as long as uncertainties persist.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.